Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ONS

Oncobiologics (ONS) Stock Price, News & Analysis

Oncobiologics logo

About Oncobiologics Stock (NASDAQ:ONS)

Advanced Chart

Key Stats

Today's Range
$2.01
$2.22
50-Day Range
$0.72
$7.40
52-Week Range
$0.57
$1.53
Volume
1.59 million shs
Average Volume
69,024 shs
Market Capitalization
$149.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ONS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncobiologics and its competitors with MarketBeat's FREE daily newsletter.

ONS Stock News Headlines

Gold is soaring. Here’s how to get paid from it
Gold just broke through $3,300… And while the headlines shout about price targets, something even more powerful is happening behind the scenes… Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge. No trading gold futures. No mining stocks. No vaults. Just a simple fund delivering monthly payouts — like clockwork.
Are Away Carry-Ons Worth the Hype?
ONS - the Office of National Statistics
See More Headlines

ONS Stock Analysis - Frequently Asked Questions

Oncobiologics (ONS) raised $35 million in an initial public offering (IPO) on Friday, May 13th 2016. The company issued 5,800,000 shares at $6.00 per share. Jefferies and Barclays acted as the underwriters for the IPO and Cantor Fitzgerald & Co. was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oncobiologics investors own include CRISPR Therapeutics (CRSP), Network-1 Technologies (NTIP), Allena Pharmaceuticals (ALNA), Intra-Cellular Therapies (ITCI), Cidara Therapeutics (CDTX), Neuralstem (CUR) and Exelixis (EXEL).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:ONS
Previous Symbol
NYSE:ONS
CIK
1649989
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$38.84 million
Net Margins
-464.47%
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-93.28%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.41
Quick Ratio
0.41

Sales & Book Value

Annual Sales
$3.81 million
Price / Sales
38.28
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.36) per share
Price / Book
-1.49

Miscellaneous

Outstanding Shares
72,200,000
Free Float
N/A
Market Cap
$145.84 million
Optionable
Not Optionable
Beta
-0.27
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:ONS) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners